David M. Thomas
Peter MacCallum Cancer Centre
East Melbourne
Victoria
Australia
Name/email consistency: high
- Specific targets in sarcoma and developmental therapeutics. Thomas, D.M., Wagner, A.J. J. Natl. Compr. Canc. Netw (2010)
- Wnts, bone and cancer. Thomas, D.M. J. Pathol. (2010)
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Thomas, D., Henshaw, R., Skubitz, K., Chawla, S., Staddon, A., Blay, J.Y., Roudier, M., Smith, J., Ye, Z., Sohn, W., Dansey, R., Jun, S. Lancet Oncol. (2010)
- Giant cell tumour of bone. Thomas, D.M., Skubitz, K.M. Curr. Opin. Oncol (2009)
- Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management. Thomas, D.M., O'Sullivan, B., Gronchi, A. Expert. Rev. Anticancer. Ther (2009)
- Adolescents and young adults with cancer: the challenge. Thomas, D.M. Palliative. &. Supportive. Care (2007)
- Epigenetic modifications in osteogenic differentiation and transformation. Thomas, D., Kansara, M. J. Cell. Biochem. (2006)
- Adolescent and young adult cancer: a revolution in evolution?. Thomas, D.M., Seymour, J.F., O'Brien, T., Sawyer, S.M., Ashley, D.M. Intern. Med. J (2006)
- Molecular medicine: a clinician's primer on microarrays. Thomas, D.M., Fleming, N.I., Holloway, A.J., Bowtell, D.D. Intern. Med. J (2004)
- Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. Thomas, D.M., Johnson, S.A., Sims, N.A., Trivett, M.K., Slavin, J.L., Rubin, B.P., Waring, P., McArthur, G.A., Walkley, C.R., Holloway, A.J., Diyagama, D., Grim, J.E., Clurman, B.E., Bowtell, D.D., Lee, J.S., Gutierrez, G.M., Piscopo, D.M., Carty, S.A., Hinds, P.W. J. Cell Biol. (2004)